Genomic information at the service of human health and its environment
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
GenoScreen and ScienceVision announce an agreement to commercialize the Deeplex® Myc-TB test in Malaysia, Myanmar and Brunei.
Tuberculosis has been a major scourge since antiquity. The fight against this disease requires ever more efficient technologies. GenoScreen, a French biotech company, has recently developed a new weapon for predicting antibiotic resistance in the germs responsible for this disease. This new test,...
The innovative Deeplex® Myc-TB test for antibiotic resistance prediction in tuberculosis, created by GenoScreen, has been evaluated by an Indian research team. By testing approximately 40 clinical samples, this study validates the use of Deeplex® Myc-TB, by demonstrating its usability in hospital...
New horizons in high throughput sequencing (DNA/RNA)
Join us for the Webinar "New horizons in high throughput sequencing (DNA/RNA)", organized by Adebiotech on Tuesday, June 15, 2021, from 10:00 to 12:30. Plus...
From October 5 to 7, 2021
IN-COSMETICS GLOBAL, Barcelona, Spain
Meet us at IN-COSMETICS GLOBAL from October 5 to 7, 2021 in Barcelona, Spain. More information